Latest News

New COVID-19 Vaccines That Target KP.2 Variant Available


 

One-Time Dosing

Although the updated mRNA vaccine is currently recommended as a one-time dose, Dr. Cennimo said he can envision a scenario later in the season when a second dose is recommended for the elderly and those at high risk for severe illness. Dr. Cennimo said that he strongly agrees with the recommendations that everyone aged 6 months and older receive an updated COVID-19 vaccine. Older age remains the prime risk factor, but anyone can become infected, he said.

Predicting a prime time to get vaccinated is tricky because no one knows when the expected rise in winter cases will occur, said Dr. Cennimo.

“We know from years of flu vaccine data that some number of people who delay the vaccine will never return and will miss protection,” he said. Therefore, delaying vaccination is not recommended. Dr. Cennimo plans to follow his habit of getting vaccinated in early October. “I anticipate the maximal effectiveness of the vaccine will carry me through the winter,” he said.

Data support the safety and effectiveness for both flu and COVID vaccines if they are given together, and some research on earlier versions of COVID vaccines suggested that receiving flu and COVID vaccines together might increase the antibody response against COVID, but similar studies of the updated version have not been done, Dr. Cennimo said.

Clinicians may have to overcome the barrier of COVID fatigue to encourage vaccination, Dr. Cennimo said. Many people say they “want it to be over,” he said, but SARS-CoV-2, established as a viral respiratory infection, shows no signs of disappearing. In addition, new data continue to show higher mortality associated with COVID-19 than with influenza, he said.

“We need to explain to our patients that COVID-19 is still here and is still dangerous. The yearly influenza vaccination campaigns should have established and normalized the idea of an updated vaccine targeted for the season’s predicated strains is expected,” he emphasized. “We now have years of safety data behind these vaccines, and we need to make a strong recommendation for this protection,” he said.

COVID-19 vaccines are covered by private insurance, as well as by Medicare and Medicaid, according to the CDC. Vaccination for uninsured children is covered through the Vaccines for Children Program.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

New Moderna vaccine to work against recent COVID variant
MDedge Endocrinology
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
MDedge Endocrinology
COVID booster may transiently raise glucose levels in T1D
MDedge Endocrinology
People with long COVID have specific blood biomarkers, study says
MDedge Endocrinology
Study: Unexpected vaginal bleeding rises after COVID vaccination
MDedge Endocrinology
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
MDedge Endocrinology
Five Bold Predictions for Long COVID in 2024
MDedge Endocrinology
Hormones and Viruses Influence Each Other: Consider These Connections in Your Patients
MDedge Endocrinology
Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers
MDedge Endocrinology
New mRNA Vaccines in Development for Cancer and Infections
MDedge Endocrinology